SAN DIEGO, Aug. 11, 2021 /PRNewswire/ — Robbins Geller Rudman & Dowd LLP announces that the Zymergen class action lawsuit charges Zymergen Inc. (NASDAQ: ZY), certain of its officers and directors, and the underwriters of Zymergen’s April 2021 initial public…
NOTICE: Investors with Substantial Losses Have Opportunity to Lead the Zymergen Inc. Class Action Lawsuit – ZY
Share this article
More News
Analysts reset Broadcom stock price target
May 21, 2026
Lumentum Stock Analysis: Buy or Sell?
May 21, 2026